- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: carfilzomib
Total 227 results
-
Andrew Yee, MDJanssen Research & Development, LLC; AmgenRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in RelapseUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusActive, not recruiting
-
European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaNetherlands, Italy
-
PETHEMA FoundationActive, not recruiting
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
University Hospital, ToulouseCelgene; Onyx Therapeutics, Inc.UnknownMultiple MyelomaFrance
-
Gilead SciencesActive, not recruitingMultiple MyelomaUnited States, Czechia, Canada
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
University College, LondonCompleted
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
Criterium, Inc.AmgenCompleted
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
Merck Sharp & Dohme LLCTerminated
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
TakedaCompleted
-
Mario BoccadoroActive, not recruiting
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Siyang LengCompleted
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
AmgenInnovative Therapies For Children with Cancer Consortium; Therapeutic Advances...Active, not recruitingAcute Lymphoblastic Leukemia (ALL)Spain, United Kingdom, United States, Korea, Republic of, Czechia, France, Russian Federation, Saudi Arabia, Thailand, Canada, Italy, Singapore, Turkey, Taiwan, Portugal, Poland, Romania, Brazil, Australia, Greece, Argentina, Mexico, Austr... and more
-
Hackensack Meridian HealthAmgenRecruitingMultiple MyelomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
Washington University School of MedicineCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, Japan, United Kingdom, France, Brazil
-
PETHEMA FoundationActive, not recruitingNewly Diagnosed Multiple MyelomaSpain
-
Cairo UniversityNot yet recruitingIVF | Endometrial ReceptivityEgypt
-
PfizerActive, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Multiple MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Belgium, Canada, France, Germany, Italy, Japan, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
CelgeneNot yet recruitingMultiple MyelomaChina, Australia, United States, Argentina, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Korea, Republic of, Norway, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
PfizerCompletedAdvanced Multiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Juul Labs, Inc.Battelle Memorial Institute; Los Angeles Clinical TrialsCompletedElectronic Cigarette UseUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Sun Yat-sen UniversityCompleted
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States